CLOs on the Move

Center for Diagnostic Imaging

www.mycdi.com

 
What`s best for each patient drives our business. Through Center for Diagnostic Imaging`s national network, including Insight Imaging, we partner with healthcare providers to do what we do best — manage and deliver high-quality medical imaging (i.e. MRI, PET/CT, etc.) and related services (i.e. injections for pain) to enhance patient care. CDI offers the highest quality of care through a network of outpatient imaging centers and mobile facilities in more than thirty states. Headquartered in Minneapolis, Minnesota; the organization serves more than one million patients a year through a diverse set of customers including healthcare providers, managed care organizations, hospitals, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.mycdi.com
  • 5775 Wayzata Blvd Ste 845
    Minneapolis, MN USA 55416
  • Phone: 763.398.4650

Executives

Name Title Contact Details
Anh Kremer
Deputy General Counsel Profile
Anh Kremer
Chief Administrative Officer Profile

Similar Companies

Sterilmed

Sterilmed is a Maple Grove, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

American Medical Vision Technologies

American Medical Vision Technologies LLC is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

American Medical Depot

American Medical Depot is a Opa Locka, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RapidAI

RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. From home to hospital and ER to OR, RapidAI is leading the next evolution of clinical decision-making and patient workflow, bringing the end-to-end patient journey into focus. Based on intelligence gained from over 4 million scans in more than 2000 hospitals in over 60 countries, the Rapid® platform transforms care coordination, offering care teams a level of patient visibility never before possible, saving lives, time and money.

LuxCath

LuxCath is the leader in using fluorescence and optics to directly view lesions during cardiac ablation procedures. The company`s breakthrough technology offers the potential for dramatic evolution in the way ablation procedures are performed by assessing tissue contact and enabling direct lesion progression monitoring. LuxCath`s patented solution aims to ensure the quality of catheter lesions at the moment they are made. LuxCath enables constant optical tissue contact assessment and provides valuable lesion formation and progression information during each ablation.